| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3521700
[patent_doc_number] => 05530124
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/269320
[patent_app_country] => US
[patent_app_date] => 1994-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15928
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 800
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530124.pdf
[firstpage_image] =>[orig_patent_app_number] => 269320
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/269320 | Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors | Jun 29, 1994 | Issued |
Array
(
[id] => 3472840
[patent_doc_number] => 05476847
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-19
[patent_title] => 'Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/267630
[patent_app_country] => US
[patent_app_date] => 1994-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15449
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/476/05476847.pdf
[firstpage_image] =>[orig_patent_app_number] => 267630
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/267630 | Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors | Jun 28, 1994 | Issued |
Array
(
[id] => 3688806
[patent_doc_number] => 05696154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Brefeldin A derivatives and their utility in the treatment of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/267525
[patent_app_country] => US
[patent_app_date] => 1994-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 45
[patent_no_of_words] => 3975
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/696/05696154.pdf
[firstpage_image] =>[orig_patent_app_number] => 267525
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/267525 | Brefeldin A derivatives and their utility in the treatment of cancer | Jun 28, 1994 | Issued |
| 08/267695 | VITRONECTIN RECEPTOR ANTAGONISTS | Jun 28, 1994 | Abandoned |
Array
(
[id] => 3608669
[patent_doc_number] => 05534188
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-09
[patent_title] => 'Acetylene derivatives, process for producing the same, liquid crystal composition containing the same as an active ingredient, and liquid crystal element using said liquid crystal composition'
[patent_app_type] => 1
[patent_app_number] => 8/256051
[patent_app_country] => US
[patent_app_date] => 1994-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22003
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/534/05534188.pdf
[firstpage_image] =>[orig_patent_app_number] => 256051
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/256051 | Acetylene derivatives, process for producing the same, liquid crystal composition containing the same as an active ingredient, and liquid crystal element using said liquid crystal composition | Jun 23, 1994 | Issued |
Array
(
[id] => 3585711
[patent_doc_number] => 05549974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof'
[patent_app_type] => 1
[patent_app_number] => 8/265090
[patent_app_country] => US
[patent_app_date] => 1994-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 18503
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/549/05549974.pdf
[firstpage_image] =>[orig_patent_app_number] => 265090
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/265090 | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof | Jun 22, 1994 | Issued |
Array
(
[id] => 3545182
[patent_doc_number] => 05554644
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-10
[patent_title] => 'Tachykinin (NK.sub.2) antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/255491
[patent_app_country] => US
[patent_app_date] => 1994-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8606
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/554/05554644.pdf
[firstpage_image] =>[orig_patent_app_number] => 255491
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255491 | Tachykinin (NK.sub.2) antagonists | Jun 7, 1994 | Issued |
Array
(
[id] => 3555976
[patent_doc_number] => 05543433
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Azine-substituted phenylacetic acid derivatives and fungicides containing these'
[patent_app_type] => 1
[patent_app_number] => 8/254052
[patent_app_country] => US
[patent_app_date] => 1994-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55684
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543433.pdf
[firstpage_image] =>[orig_patent_app_number] => 254052
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/254052 | Azine-substituted phenylacetic acid derivatives and fungicides containing these | Jun 2, 1994 | Issued |
Array
(
[id] => 3521966
[patent_doc_number] => 05530139
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Condensed heterocyclic compound with a sulfonic acid group and process for producing the same'
[patent_app_type] => 1
[patent_app_number] => 8/251266
[patent_app_country] => US
[patent_app_date] => 1994-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4950
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 434
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530139.pdf
[firstpage_image] =>[orig_patent_app_number] => 251266
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/251266 | Condensed heterocyclic compound with a sulfonic acid group and process for producing the same | May 30, 1994 | Issued |
| 08/250213 | PROCESS FOR THE PRODUCTION OF OLEFIN ACID ANHYDRIDES AND ESTERS THEREOF | May 26, 1994 | Abandoned |
Array
(
[id] => 3498583
[patent_doc_number] => 05532361
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-02
[patent_title] => 'Spiro-pyranic compounds endowed with photochromic characteristics'
[patent_app_type] => 1
[patent_app_number] => 8/241759
[patent_app_country] => US
[patent_app_date] => 1994-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6905
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/532/05532361.pdf
[firstpage_image] =>[orig_patent_app_number] => 241759
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/241759 | Spiro-pyranic compounds endowed with photochromic characteristics | May 11, 1994 | Issued |
| 08/236204 | NOVEL RACEMIC AND OPTIONALLY PURE 5S-(P-METHOXYPHENYL-4R-CARBOETHOXY-1,3,2-DIOXATHIOLANE-2-OXIDE AND A PROCESS FOR THE PREPARATION OF 5S-(P-ALKOXYPHENYL)-4-CARBOALKOXY-1,3,2-DIOXATHIOLANE-2-OXIDE | May 1, 1994 | Abandoned |
Array
(
[id] => 3581412
[patent_doc_number] => 05498609
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-12
[patent_title] => 'Benzoazepinyl compounds as oxytocin and vasopressin antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/211887
[patent_app_country] => US
[patent_app_date] => 1994-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32067
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/498/05498609.pdf
[firstpage_image] =>[orig_patent_app_number] => 211887
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/211887 | Benzoazepinyl compounds as oxytocin and vasopressin antagonists | Apr 19, 1994 | Issued |
Array
(
[id] => 3648362
[patent_doc_number] => 05637689
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Process for the preparation of alkylimidazolidone (meth) acrylate(s)'
[patent_app_type] => 1
[patent_app_number] => 8/223608
[patent_app_country] => US
[patent_app_date] => 1994-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2268
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637689.pdf
[firstpage_image] =>[orig_patent_app_number] => 223608
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/223608 | Process for the preparation of alkylimidazolidone (meth) acrylate(s) | Apr 5, 1994 | Issued |
| 08/201283 | NITROGEN-CONTAINING CYCLOHETERO CYCLO-HETEROAMINOARYL DERIVATIVES FOR CNS DISORDERS | Feb 22, 1994 | Abandoned |
| 08/186745 | COMPOSITIONS USEFUL FOR INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR | Jan 24, 1994 | Abandoned |
Array
(
[id] => 3614989
[patent_doc_number] => 05565603
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-15
[patent_title] => 'Process for manufacturing dialkyl carbonate from urea and alcohol'
[patent_app_type] => 1
[patent_app_number] => 8/170468
[patent_app_country] => US
[patent_app_date] => 1993-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10292
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/565/05565603.pdf
[firstpage_image] =>[orig_patent_app_number] => 170468
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/170468 | Process for manufacturing dialkyl carbonate from urea and alcohol | Dec 19, 1993 | Issued |
| 08/167600 | EPOXIDE-CONTAINING COMPOUNDS | Dec 12, 1993 | Abandoned |
Array
(
[id] => 3587011
[patent_doc_number] => 05552397
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase'
[patent_app_type] => 1
[patent_app_number] => 8/160540
[patent_app_country] => US
[patent_app_date] => 1993-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74837
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552397.pdf
[firstpage_image] =>[orig_patent_app_number] => 160540
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/160540 | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase | Nov 30, 1993 | Issued |
Array
(
[id] => 3584419
[patent_doc_number] => 05580990
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'Pt-containing compound, process for its preparation, and application of such compounds'
[patent_app_type] => 1
[patent_app_number] => 7/975586
[patent_app_country] => US
[patent_app_date] => 1993-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3084
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580990.pdf
[firstpage_image] =>[orig_patent_app_number] => 975586
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/975586 | Pt-containing compound, process for its preparation, and application of such compounds | Oct 28, 1993 | Issued |